- Home
- RGF vs IMNN Comparison
RGF vs IMNN Comparison
Compare RGF & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGF
- IMNN
- Stock Information
- Founded
- RGF 2016
- IMNN 1982
- Country
- RGF United States
- IMNN United States
- Employees
- RGF N/A
- IMNN N/A
- Industry
- RGF Packaged Foods
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- RGF Consumer Staples
- IMNN Health Care
- Exchange
- RGF Nasdaq
- IMNN Nasdaq
- Market Cap
- RGF 8.3M
- IMNN 15.1M
- IPO Year
- RGF 2021
- IMNN 1985
- Fundamental
- Price
- RGF $0.43
- IMNN $1.04
- Analyst Decision
- RGF Buy
- IMNN Strong Buy
- Analyst Count
- RGF 2
- IMNN 1
- Target Price
- RGF $2.25
- IMNN $14.00
- AVG Volume (30 Days)
- RGF 93.2K
- IMNN 649.0K
- Earning Date
- RGF 09-17-2024
- IMNN 08-14-2024
- Dividend Yield
- RGF N/A
- IMNN N/A
- EPS Growth
- RGF N/A
- IMNN N/A
- EPS
- RGF N/A
- IMNN N/A
- Revenue
- RGF $156,379,000.00
- IMNN N/A
- Revenue This Year
- RGF $23.67
- IMNN N/A
- Revenue Next Year
- RGF N/A
- IMNN N/A
- P/E Ratio
- RGF N/A
- IMNN N/A
- Revenue Growth
- RGF 18.88
- IMNN N/A
- 52 Week Low
- RGF $0.21
- IMNN $0.48
- 52 Week High
- RGF $4.34
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- RGF 45.34
- IMNN 44.29
- Support Level
- RGF $0.39
- IMNN $1.09
- Resistance Level
- RGF $0.45
- IMNN $1.39
- Average True Range (ATR)
- RGF 0.04
- IMNN 0.10
- MACD
- RGF 0.00
- IMNN -0.01
- Stochastic Oscillator
- RGF 48.10
- IMNN 12.50
About RGF The Real Good Food Company Inc.
The Real Good Food Company Inc is an high-growth, branded, health- and wellness-focused frozen food company. It develops, markets, and manufactures delicious and convenient comfort foods designed to be high in protein, low in sugar, and made from gluten- and grain-free ingredients that are intended to be sold in the health and wellness segment of the frozen food category. All of its revenue is derived from the United States.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.